Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29771328 | 1.00 | MEN1 (0.36) | MEN1KMT2ATSHRCYP1A2CYP2C9 | |
| SCHEMBL29114642 | 1.00 | MEN1 (0.36) | MEN1KMT2ATSHRCYP1A2CYP2C9 | |
| SCHEMBL6386501 | 0.95 | MAPT (0.33) | MEN1KMT2ACYP1A2CYP2C19MAPT | |
| SCHEMBL66400 | 0.95 | TSHR (0.35) | MEN1KMT2ATSHRCYP1A2CYP2C9 | |
| SCHEMBL29771136 | 0.95 | TSHR (0.35) | MEN1KMT2ATSHRCYP1A2CYP2C9 | |
| SCHEMBL32674607 | 0.93 | MEN1 (0.32) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL23149337 | 0.93 | MEN1 (0.33) | MEN1KMT2A | |
| SCHEMBL32674610 | 0.92 | MEN1 (0.33) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL3685897 | 0.92 | MEN1 (0.33) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL392038 | 0.88 | MEN1 (0.34) | MEN1KMT2ATSHRMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 401 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240108555-A1 | UNREACTIVE TRANSFER SPLINTS | VOCO GMBH (DE) | 2024-04-04 | — | — | US | claimed |
| EP-4338702-A1 | NON-REACTIVE TRANSFER RAILS | VOCO GmbH (DE) | 2024-03-20 | — | — | EP | claimed |
| US-9925124-B2 | Dental composition suitable for grinding with automatic grinding apparatus | KABUSHIKI KAISHA SHOFU (JP) | 2018-03-27 | — | — | US | claimed |
| US-4898899-A | Adhesive composition | TOAGOSEI CHEMICAL INDUSTRY CO. (JP) | 1990-02-06 | — | — | US | claimed |
| EP-4091578-B1 | METHOD FOR PRODUCING PLATE DENTURE | TOKUYAMA DENTAL CORP (JP) | 2024-10-09 | — | — | EP | disclosed |
| WO-2024150826-A1 | DENTAL COMPOSITION | クラレノリタケデンタル株式会社 | 2024-07-18 | — | — | WO | disclosed |
| US-12030970-B2 | Curable composition and stereolithographic resin composition comprising same | KURARAY CO., LTD. (JP) | 2024-07-09 | — | — | US | disclosed |
| US-20240199494-A1 | ZIRCONIA MOLDED BODY, ZIRCONIA PRE-SINTERED BODY, AND ZIRCONIA SINTERED BODY, AND METHODS OF PRODUCTION THEREOF | Kuraray Noritake Dental lnc. (JP) | 2024-06-20 | — | — | US | disclosed |
| US-20240173211-A1 | DENTAL RESIN-REINFORCED GLASS IONOMER CEMENT KIT | SHOFU INC. (JP) | 2024-05-30 | — | — | US | disclosed |
| US-20240173212-A1 | HIGH TRANSPARENCY AND LONG-RELEASE DENTAL RESIN COMPOSITION CONTAINING CORE-SHELL POROUS STRUCTURED NANOPARTICLES AND METHOD FOR PREPARING THE SAME | JNP Nature Co., Ltd. (KR) | 2024-05-30 | — | — | US | disclosed |
| US-20240164993-A1 | ORGANOSILICON COMPOUND AND DENTAL COMPOSITION CONTAINING SAME | KURARAY NORITAKE DENTAL INC. (JP) | 2024-05-23 | — | — | US | disclosed |
| EP-3848418-B1 | DENTAL CURABLE COMPOSITION AND METHOD FOR PRODUCING DENTAL CURABLE COMPOSITION | TOKUYAMA DENTAL CORP (JP) | 2024-05-22 | — | — | EP | disclosed |
| US-5260476-A | Dental restoration | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1993-11-09 | — | — | US | disclosed |
| US-5171763-A | A dental composite of a monomer containing poly(3,4-carboxylic benzoic acid and acrylic ester moities, an ion leachable filler and an initiator; high adhesion and strength; discoloration inhibition | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1992-12-15 | — | — | US | disclosed |
| US-4898899-A | Adhesive composition | TOAGOSEI CHEMICAL INDUSTRY CO. (JP) | 1990-02-06 | — | — | US | disclosed |
| US-4394494-A | DIURETHANE TETRAACRYLATES AS POLYMERIZABLE MONOMERS | LION CORPORATION (JP) | 1983-07-19 | — | — | US | disclosed |
| US-4388421-A | PRIMERS | LION CORPORATION (JP) | 1983-06-14 | — | — | US | disclosed |
| US-4383052-A | 1-Methacryloxyethane-1,1-diphosphonic acid and its salts and dental adhesive composition containing same | LION CORPORATION (JP) | 1983-05-10 | — | — | US | disclosed |
| US-4055542-A | PEROXIDE | THREE BOND CO., LTD. (JA) | 1977-10-25 | — | — | US | disclosed |
| US-4044044-A | Anaerobic adhesive composition containing 0.05 to 20 parts per weight of phosphate esters of hydroxyacrylates per 100 parts per weight of polymerizable acrylic ester monomer | SAITO TSUTOMU | 1977-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12030970-B2 | Curable composition and stereolithographic resin composition comprising same | ARL1, ASH2L, VCL | MEN1 2530/4885KMT2A 1501/4885TSHR 4710/4885 |
| US-20240108555-A1 | UNREACTIVE TRANSFER SPLINTS | MATR3, SUGT1, DIMT1 | MEN1 2935/4885KMT2A 124/4885TSHR 4744/4885 |
| US-20240164993-A1 | ORGANOSILICON COMPOUND AND DENTAL COMPOSITION CONTAINING SAME | MSL1, ITGA1, ASH2L | MEN1 1398/4885KMT2A 1162/4885TSHR 4172/4885 |
| US-20240173211-A1 | DENTAL RESIN-REINFORCED GLASS IONOMER CEMENT KIT | GRIK1, GRIN2B, GRIK2 | MEN1 3341/4885KMT2A 455/4885TSHR 2655/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.